These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1720830)

  • 1. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
    Lahlou S; Duarte GP
    Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
    Lahlou S
    Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
    Roquebert J; Alaoui K; Morán Benito A
    J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
    Lahlou S
    Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
    Lahlou S; Duarte GP; Demenge P
    Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects in the rat of intrathecal injections of apomorphine at the thoracic spinal cord level.
    Petitjean P; Mouchet P; Pellissier G; Manier M; Feuerstein C; Demenge P
    Eur J Pharmacol; 1984 Oct; 105(3-4):355-9. PubMed ID: 6548972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA; Lokhandwala MF
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
    Celuch SM; García Mdel C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):343-9. PubMed ID: 12237748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted pressor responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms.
    Lahlou S
    Eur J Pharmacol; 2000 Nov; 408(1):51-62. PubMed ID: 11070183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
    Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
    Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.